Life Science M&A: A Pivotal Scientific Perspective
Buy Side Continued investment from PE and Multinationals Post-pandemic there has been increased and sustained investment from private equity (PE) firms into the life sciences space, however the large multiples seen during and in the immediate aftermath of the pandemic have not stood the test of time. PE investment has come from both large and … Read more